Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Loading...
Community
/
United States
/
Healthcare
/
Ekso Bionics Holdings
EKSO
Ekso Bionics Holdings
Enterprise Order Delays Will Weaken Performance But Spark Opportunity
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
26 Aug 25
Updated
26 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$4.00
5.0% undervalued
intrinsic discount
26 Aug
US$3.80
1Y
-77.4%
7D
13.4%
Loading
1Y
-77.4%
7D
13.4%
Author's Valuation
US$4.0
5.0% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$4.0
5.0% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-38m
51m
2014
2017
2020
2023
2025
2026
2028
Revenue US$51.2m
Earnings US$6.4m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
20.44%
Medical Equipment revenue growth rate
0.45%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
8.69%
Calculation
US$6.36m
Earnings '28
x
4.63x
PE Ratio '28
=
US$29.49m
Market Cap '28
US$29.49m
Market Cap '28
/
5.74m
No. shares '28
=
US$5.14
Share Price '28
US$5.14
Share Price '28
Discounted to 2025 @ 8.71% p.a.
=
US$4.00
Fair Value '25
